期刊
GENE
卷 470, 期 1-2, 页码 31-36出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.gene.2010.09.005
关键词
Galactokinase; Counterselectable markers; Recombination; Tuberculosis
资金
- NIH [AI53417, AI075805]
- Michael and Ethel L Cohen Foundation
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080619, R01AI064693, R01AI053417, F32AI075805] Funding Source: NIH RePORTER
Counterselectable markers are powerful tools in genetics because they allow selection for loss of a genetic marker rather than its presence In mycobacteria a widely used counterselectable marker is the gene encoding levan sucrase (sacB) which confers sensitivity to sucrose but frequent spontaneous inactivation complicates its use Here we show that the Escherichia coli galactokinase gene (galK) can be used as a counterselectable marker in both Mycobacterium smegmatis and Mycobacterium tuberculosis Expression of E colt galK but not the putative M tuberculosis galK conferred sensitivity to 2-deoxy galactose (2-DOG) in both M smegmatis and M tuberculosis We tested the utility of E colt galK as a counterselectable marker in mycobacterial recombination both alone and in combination with sacB We found that 0 5% 2-DOG effectively selected recombinants that had lost the galK marker with the ratio of galK loss/galK mutational inactivation of approximately 1 4 When we combined galK and sacB as dual counterselectable markers and selected for dual marker loss on 02% 2-DOG/5% sucrose 98 6-100% of sucrose/2-DOG resistant clones had undergone recombination indicating that the frequency of mutational inactivation of both markers was lower than the recombination frequency These results establish a new counterselectable marker system for use in mycobacteria that can shorten the time to generate unmarked mutations in M smegmatis and M tuberculosis (C) 2010 Elsevier B V All rights reserved
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据